Trial Profile
Planned phase III pivotal trial of serca 2a gene therapy in patients with heart failure.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 05 Mar 2014
Price :
$35
*
At a glance
- Drugs SERCA 2a gene therapy (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Sponsors Celladon
- 05 Mar 2014 New trial record